The Recall Desk
ModerateFDA (Devices)·Z-1438-2020·Announced 2020-03-11

Polymer Technology Systems Recalls PTS Detect Cotinine In Vitro Diagnostic

Polymer Technology Systems is recalling PTS Detect Cotinine in vitro diagnostic devices due to a lack of FDA 510(k) clearance.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is driven by a regulatory compliance issue (lack of 510(k) clearance) rather than a reported safety hazard, injury, or contamination, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

Polymer Technology Systems, Inc. is recalling the PTS Detect Cotinine in vitro diagnostic, Reference No. 3061, UPC 381933061017. The product is used for the quantitative measurement of the nicotine metabolite cotinine in capillary or venous whole blood to determine if an individual has been exposed to nicotine.

The firm is removing the product from the market after discussions with the FDA due to a lack of 510(k) clearance. The recall involves 6,790 units.

The product was distributed domestically nationwide and internationally to Belgium, South Africa, South Korea, and Poland. Affected lots include codes 1811715, 1831313, 1831324, and 1831325.

The recalled product

Product
PTS Detect Cotinine, Ref. No. 3061, UPC 381933061017 in vitro diagnostic - Product Usage: The PTS Detect cotinine system provides quantitative measurement of the nicotine metabolite cotinine (25 200 ng/mL) in capillary (fingerstick) or venous whole blood. The test is for professi
Affected units
6,790

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 1811715 1831313 1831324 1831325

Distribution

Distributed nationwide across the United States.